Menú de navegación

award_recipients_title

award-recipients-2021

Award Recipients 2021


Christoph R. Behem, MD
Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine
University Medical Center Hamburg-Eppendorf
Hamburg, Germany


Project: 
The use of Albumin for optimization of spinal cord microcirculatory blood‐flow and oxygenation in an experimental model of spinal cord ischemia.


Martin Sebastian Winkler, MD
Department of Anesthesiology and Intensive Care
University Medicine Goettingen
Goettingen, Germany

Project: Non-oncotic effects of albumin as a carrier of sphingosine-1-phosphate for the restoration of endothelial cell barriers and immune cell function in sepsis.


award-recipients-2020

Award Recipients 2020


Mar Hernández, PhD
Vall d'Hebron Research Institute
Hospital Vall d'Hebron
Barcelona, Spain


Project: 
Nanotechnology albumin-based approach for the diagnosis and treatment of Alzheimer's Disease


Hafid Ait-Oufella, MD, PhD
Division of Intensive Care Medicine
St-Antoine Hospital
Paris, France

Project: Impact of albumin infusion on tissue perfusion in septic shock patients. A prospective pathophysiological study


award-recipients-2019

Award Recipients 2019


Prof. Davide Chiumello
Direttore SC Anestesia e Rianimazione
Ospedale San Paolo – Polo Universitario, ASST Santi Paolo e Carlo
Milan, Italy


Project: 
Effect of volume EXpansion witH ALbumin vs. crystalloid on EIT-derived expiratory lung impedance in critically ill, hemodynamically unstable patients. A single-blind, randomized and controlled study (the EXHALE study)


Aurora Pujol, MD, PhD
Neurometabolic Diseases Laboratory
Bellvitge Biomedical Research Institute IDIBELL- Hospital Duran i Reynals
Barcelona, Spain

Project: Human albumin in plasma exchange as a novel approach for adrenoleukodystrophy


award-recipients-2018

Award Recipients 2018


Paolo Caraceni, MD
Department of Medical and Surgical Sciences
Alma Mater Studiorum University of Bologna
Bologna, Italy

Project: 
Long‐term albumin administration in patients with decompensated cirrhosis: clinical and pathophysiological implications


Hanadi Sleiman, PhD
Department of Chemistry
McGill University
Montreal, Canada

Project: Albumin as a passive targeting agent: effect of the protein binding on stability, bio distribution and therapeutic outcome of oligonucleotides and DNA nanoparticles


award-recipients-2017

Award Recipients 2017


Anna ROIG, PhD
Institut de Ciència de Materials de Barcelona
Consejo Superior de Investigaciones Científicas
Bellaterra (Barcelona), Spain

Project: 
Albumin-iron oxide nanocages


Karl OETTL, PhD
Institute of Physiological Chemistry
Medical University of Graz
Graz, Austria

Project: Effect of albumin redox state on the intracellular redox balance in cell culture


award-recipients-2016

Award Recipients 2016


Joan CLÀRIA, Bsc, PhD
Hospital Clínic
Faculty of Medicine, University of Barcelona
Barcelona, Spain

Project: 
Effects of native (reduced) and oxidized albumin forms on human leukocyte function


Rudolf E. STAUBER, MD
Division of Gastroenterology and Hepatology
Department of Internal Medicine, Medical University of Graz
Graz, Austria

Project: Effect of albumin infusion on oxidative albumin modification and albumin binding capacity


award-recipients-2015

Award Recipients 2015


Pietro CAIRONI, MD
Department of Pathophysiology and Transplantation
Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, University of Milan
Milan, Italy

Project: Albumin administration as a therapeutic approach to attenuate sepsis-induced glycocalyx disruption in human septic shock


James RUSSELL, MD
University of British Columbia
Principal Investigator
Centre for Heart Lung Innovation, St. Paul's Hospital
Vancouver, BC, Canada

Project: Is heparin-binding protein a mechanism of Albumin's efficacy in human septic shock?